Document Detail

Diatrizoate meglumine (Hypaque) treatment for sudden hearing loss.
MedLine Citation:
PMID:  459656     Owner:  NLM     Status:  MEDLINE    
During the 24 month period ending in December 1978, 31 patients with sudden idiopathic sensorineural hearing loss were treated with vasodilators and Hypaque. Fifteen patients met the treatment criteria of being treated within the first month following onset, no vertigo, and the hearing loss was not complete. Twelve patients (80%) had complete return of their hearing. Two patients (13%) had partial return of their hearing, and 1 patient (6%) had no response to treatment. Of the 16 patients treated who did not meet the criteria, 6 patients (38%) had complete return of their hearing. Eight patients (50%) had partial return of their hearing and 2 patients (12%) had no return of their hearing.
J R Emmett; J J Shea
Related Documents :
7769946 - Performance of prelingually and postlingually deaf patients using single-channel or mul...
10993456 - Air-bone gap and resonant frequency in large vestibular aqueduct syndrome.
3970796 - Non-verbal response to intraoperative conversation.
19926286 - Salient and placebo vibrotactile feedback are equally effective in reducing sway in bil...
20557996 - Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary...
6635736 - High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Laryngoscope     Volume:  89     ISSN:  0023-852X     ISO Abbreviation:  Laryngoscope     Publication Date:  1979 Aug 
Date Detail:
Created Date:  1979-09-27     Completed Date:  1979-09-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8607378     Medline TA:  Laryngoscope     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1229-38     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Diatrizoate / analogs & derivatives*
Diatrizoate Meglumine / therapeutic use*
Hearing Loss, Sensorineural / diagnosis,  drug therapy*
Hearing Loss, Sudden / diagnosis,  drug therapy*
Hearing Tests
Middle Aged
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Vasodilator Agents; 117-96-4/Diatrizoate; 131-49-7/Diatrizoate Meglumine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Amyloidosis presenting as a mass in the neck.
Next Document:  Metastatic tumors to the sphenoid sinus.